inclusion criteria: each subject must meet all of the following criteria to be randomized in this study: 1. subject is a healthy male or female subject, aged between 19 to 55 years (both inclusive). health is defined as no clinically relevant abnormalities identified by investigator's decision based on a detailed medical history, full physical examination, including blood pressure, heart rate, respiratory rate, and body temperature measurements, 12-lead electrocardiogram (ecg) and clinical laboratory tests prior to the study drug administration. 2. subject is confirmed as negative in sars-cov-2 infection test on screening and day -1 visits. 3. subject with a body weight of ≥ 50 kg and a body mass index between 18.0 and 29.9 kg/m2 (both inclusive). 4. subject is able to understand and to comply with protocol requirements, instructions, and restrictions. 5. subject voluntarily agrees to participate in this study and has given a written informed consent prior to undergoing any of the screening procedures.

inclusion criteria: each subject must meet all of the following criteria to be randomized in this study: 1. subject is a healthy male or female subject, aged between 19 to 55 years (both inclusive). health is defined as no clinically relevant abnormalities identified by investigator's decision based on a detailed medical history, full physical examination, including blood pressure, heart rate, respiratory rate, and body temperature measurements, 12-lead electrocardiogram (ecg) and clinical laboratory tests prior to the study drug administration. 2. subject is confirmed as negative in sars-cov-2 infection test on screening and day -1 visits. 3. subject with a body weight of ≥ 50 kg and a body mass index between 18.0 and 29.9 kg/m2 (both inclusive). 4. subject is able to understand and to comply with protocol requirements, instructions, and restrictions. 5. subject voluntarily agrees to participate in this study and has given a written informed consent prior to undergoing any of the screening procedures.

inclusion criteria: each subject must meet all of the following criteria to be randomized in this study: subject is a healthy male or female subject, aged between 19 to 55 years (both inclusive). health is defined as no clinically relevant abnormalities identified by investigator's decision based on a detailed medical history, full physical examination, including blood pressure, heart rate, respiratory rate, and body temperature measurements, 12-lead electrocardiogram (ecg) and clinical laboratory tests prior to the study drug administration. subject is confirmed as negative in sars-cov-2 infection test on screening and day -1 visits. subject with a body weight of ≥ 50 kg and a body mass index between 18.0 and 29.9 kg/m2 (both inclusive). subject is able to understand and to comply with protocol requirements, instructions, and restrictions. subject voluntarily agrees to participate in this study and has given a written informed consent prior to undergoing any of the screening procedures.

inclusion criteria: each subject must meet all of the following criteria to be randomized in this study: subject is a healthy male or female subject, aged between 19 to 55 years (both inclusive). health is defined as no clinically relevant abnormalities identified by investigator's decision based on a detailed medical history, full physical examination, including blood pressure, heart rate, respiratory rate, and body temperature measurements, 12-lead electrocardiogram (ecg) and clinical laboratory tests prior to the study drug administration. subject is confirmed as negative in sars-cov-2 infection test on screening and day -1 visits. subject with a body weight of ≥ 50 kg and a body mass index between 18.0 and 29.9 kg/m2 (both inclusive). subject is able to understand and to comply with protocol requirements, instructions, and restrictions. subject voluntarily agrees to participate in this study and has given a written informed consent prior to undergoing any of the screening procedures.

inclusion criteria: each subject must meet all of the following criteria to be randomized in this study: 1. subject is a healthy male or female subject, aged between 19 to 55 years (both inclusive). health is defined as no clinically relevant abnormalities identified by investigator's decision based on a detailed medical history, full physical examination, including blood pressure, heart rate, respiratory rate, and body temperature measurements, 12-lead electrocardiogram (ecg) and clinical laboratory tests prior to the study drug administration. 2. subject is confirmed as negative in sars-cov-2 infection test on screening and day -1 visits. 3. subject with a body weight of ≥ 50 kg and a body mass index between 18.0 and 29.9 kg/m2 (both inclusive). 4. subject is able to understand and to comply with protocol requirements, instructions, and restrictions. 5. subject voluntarily agrees to participate in this study and has given a written informed consent prior to undergoing any of the screening procedures.

inclusion criteria: each subject must meet all of the following criteria to be randomized in this study: 1. subject is a healthy male or female subject, aged between 19 to 55 years (both inclusive). health is defined as no clinically relevant abnormalities identified by investigator's decision based on a detailed medical history, full physical examination, including blood pressure, heart rate, respiratory rate, and body temperature measurements, 12-lead electrocardiogram (ecg) and clinical laboratory tests prior to the study drug administration. 2. subject is confirmed as negative in sars-cov-2 infection test on screening and day -1 visits. 3. subject with a body weight of ≥ 50 kg and a body mass index between 18.0 and 29.9 kg/m2 (both inclusive). 4. subject is able to understand and to comply with protocol requirements, instructions, and restrictions. 5. subject voluntarily agrees to participate in this study and has given a written informed consent prior to undergoing any of the screening procedures.